THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY
BSACI is the UK's leading professional society for allergy and clinical immunology, serving over 1,000 healthcare professional members with clinical guidelines, accredited education, an annual conference, patient registries, and representation to NICE and the Royal College of Physicians.
- Company typePrivate
- Founded1948
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY does
The British Society for Allergy and Clinical Immunology (BSACI) is a UK-registered charity (No. 1069199) and professional medical society founded in 1948 (originally as the British Allergy Society), headquartered in Battersea, London. It serves over 1,000 healthcare professional members working across allergy, clinical immunology, paediatrics, ENT, dermatology, and respiratory medicine. Its core products and services include tiered professional membership (annual fees from £11 for students to £148 for non-trainee doctors), the flagship Annual Conference held at ICC Wales, the Global Allergy Online Symposium, monthly webinars and Lunch and Learn sessions, regional Primary Care Allergy Training Days, and postgraduate courses. The society also produces authoritative clinical guidelines (secondary and primary care), Allergy Action Plans developed with patient charities, patient information leaflets, the UK Fatal Anaphylaxis Registry (UKFAR), the Registry for Immunotherapy (BRIT), and the Improving Quality in Allergy Services (IQAS) accreditation standards, and operates a public Find a Clinic NHS directory.
BSACI's business model is a hybrid of subscription membership fees, corporate sponsorship (pharmaceutical and allergy-immunotherapy firms such as ALK Abello, AstraZeneca, Allergy Therapeutics), conference and event revenue, commercial meeting room hire at its London head office (£70/hour commercial rate with 20% member discount), donations, and legacies. The society is governed by an elected Council and Board of Trustees, including the President, Treasurer, Secretary, and four Vice Presidents covering Education and Training, Workforce, Services, and Science and Research. It maintains strategic alliances with the World Allergy Organisation (WAO), the European Academy of Allergy and Clinical Immunology (EAACI, via NAS Dual Membership), Allergy UK, Anaphylaxis Campaign, Asthma UK, the UK Respiratory Research Collaborative (UKRRC), and the Royal College of Physicians, and plays a coordinating role in the National Allergy Strategy Group, which helped secure the UK's first National Allergy Strategy.
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY firmographics
Firmographics- Name
- THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY
- Legal name
- The British Society for Allergy and Clinical Immunology
- Website
- https://bsaci.org
- Company type
- Private
- Founded year
- 1948
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BSACI is the UK's leading professional society for allergy and clinical immunology, serving over 1,000 healthcare professional members with clinical guidelines, accredited education, an annual conference, patient registries, and representation to NICE and the Royal College of Physicians.
- Ownership category
- akta.pro rank
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY industry classification
Industry- Product category
- Professional Medical Society Services
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
- akta.pro secondary industry
- Workforce Training, Credentialing & Clinical Protocols for Vaccination (HLAJAHAL)
Keywords
Where THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Membership Fees: Annual membership fees from healthcare professionals including allergists, immunologists, nurses, dietitians, researchers, and trainees. Fees range from £11 for students to £148 for non-trainee doctors.
- Corporate Partnerships and Industry Support: Corporate sponsors and partners fund projects, events, and activities. Examples include ALK Abello (£75,385 for Annual Conference 2025 tailored package), AstraZeneca, Allergy Therapeutics, and other pharmaceutical companies providing advertising and conference support.
- Meeting Room Hire: BSACI hires out meeting facilities at their London head office. Commercial rate is £70 per hour with 20% discount for members. Available Monday-Friday 10am-5pm.
- Annual Conference and Events: Revenue from the Annual Conference at ICC Wales, Global Allergy Online Symposium, webinars, and various educational workshops and training courses.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Student - Undergraduates |
| Subscription | Annual | Trainee & Early Career Scientists - Clinical trainees in allergy/clinical immunology or within five years of higher degree (PhD, MSc) |
| Subscription | Annual | Clinical - Nurses, Allied Health Professionals, Psychologists, Pharmacists |
| Subscription | Annual | Doctors - Non-trainee (Consultants, GPs, Medical/Dental professionals) |
| Subscription | Pay-as-you-go | Meeting Room Hire - Commercial Rate |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels10 records
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY product offering
Product offeringCore offering
BSACI is a UK professional membership society for healthcare practitioners in allergy and clinical immunology, providing tiered individual membership, evidence-based clinical guidelines for secondary and primary care, an annual scientific conference, the Global Allergy Online Symposium, webinars and training workshops, clinical and patient registries, Allergy Action Plans, and patient information resources. It serves over 1,000 members across multiple medical specialties and operates as a registered charity.
Product overview
The British Society for Allergy and Clinical Immunology (BSACI) operates as a membership-based professional society rather than a unified software product. Its portfolio consists of membership services, educational programs, clinical guidelines, registries, and patient resources. Core offerings include the annual conference and Global Allergy Online Symposium, webinars and training workshops, comprehensive secondary and primary care guidelines, Allergy Action Plans, Patient Information Leaflets, and the Research Hub database. BSACI also operates patient registries (UKFAR and BRIT), awards programs, nursing mentorship, and a Find a Clinic directory. These products function as interconnected resources supporting the allergy care community through education, standards, and research facilitation.
Differentiator
Problem solved
Functional benefit
Products and services
- BSACI Membership Annual membership program for healthcare professionals in allergy and clinical immunology, providing access to clinical guidelines, the Clinical & Experimental Allergy journal, BSACI Newsletter and Allergy Updates, discounted Annual Meeting and additional meeting rates, and BSACI Travel Fellowship preference. Tiered pricing from £11 (students) to £148 (doctors).
- BSACI Annual Conference
Quantifiable outcome
- Published 13 clinical guidelines by 2017 and continues to develop new guidelines through Standards of Care Committee
- +2 more outcomes
Companies that use THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles3 records
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered minor, core and major.
- ALK AbellominorCorporate partner for Annual Conference 2025 with £75,385 tailored package. Also purchased advertising (£2,400). Pharmaceutical company specialising in allergy immunotherapy.
- AstraZenecaminorCorporate partner for Annual Conference 2025 (£17,410). Pharmaceutical company with respiratory and allergy portfolio.
- Allergy TherapeuticsminorCorporate partner for Annual Conference 2025 (£6,875 tailored package). Specialist in allergy immunotherapy products.
- Allergy TeamminorCorporate partner for Annual Conference 2025 (£735).
- Alive DXminorCorporate partner for Annual Conference 2025 tailored package (£1,470).
- Dr Falk PharmaminorPurchased advertising (£2,900). Pharmaceutical company.
- InitiativeminorPurchased advertising (£4,800).
- MadXminorPurchased advertising (£5,300).
- World Allergy Organisation (WAO)coreBSACI is a member of WAO. Benefits include: opportunity to request endorsement and speakers for scientific programs; chance to promote the society on WAO website; access to materials for World Allergy Week; ability to contribute to WAO Position papers and publications; participation in WAO governance through committees; participation in Emerging Societies Programme.
- European Academy of Allergy and Clinical Immunology (EAACI)coreBSACI offers NAS (National Allergy Society) Dual Membership with EAACI. BSACI members receive complimentary first-year membership, followed by 30 EUR fee for second year. Collaboration on allergy education and research across Europe.
- Allergy UKmajorPatient charity collaboration. Worked together on developing Allergy Action Plans for adults and children. Part of National Allergy Strategy Group alliance lobbying for better allergy care provision.
- Anaphylaxis CampaignmajorPatient charity collaboration. Co-developed Allergy Action Plans. Both are part of National Allergy Strategy Group alliance working to improve allergy care in the UK.
- National Allergy Strategy Group (NASG)coreBSACI has been instrumental in lobbying for better provision of allergy care in this alliance with patient charities and supported by industry. Successfully advocated for UK's first National Allergy Strategy to address the allergy crisis affecting millions.
- Royal College of PhysiciansmajorBSACI provides professional representation with the RCP. Many members give evidence at Government enquiries into allergy care and represent the society on NICE guidelines.
- Asthma UKmajorCollaborates with Asthma UK to access funding opportunities for projects, grants and fellowships in allergy and respiratory research.
- UK Respiratory Research Collaborative (UKRRC)majorBSACI works closely with UKRRC, endorsing research priorities and submitting them for funding. Collaborates on basic, clinical and translational studies in Allergy and Clinical Immunology.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY competitors and assessment
Company assessmentDirect peers
- British Society for Immunology (BSI): BSI is the UK's primary immunology professional society and overlaps with BSACI on clinical immunology training, guidelines, and workforce representation. BSACI has a BSI/CIPN representative on its Council, evidencing close operational overlap.
- European Academy of Allergy and Clinical Immunology (EAACI): EAACI is the European professional society for allergy and clinical immunology, BSACI's most direct continental peer. BSACI offers members a low-cost NAS Dual Membership with EAACI, evidencing direct overlap in congresses, education, and guideline-setting for the same specialty audience.
- World Allergy Organisation (WAO): WAO is the global umbrella organisation for allergy societies. BSACI is a WAO member society and works with WAO on World Allergy Week and joint position papers, making WAO a structurally linked global peer.
Others
- Anaphylaxis Campaign: Anaphylaxis Campaign is a UK patient charity and co-developer with BSACI of Allergy Action Plans and a fellow member of the National Allergy Strategy Group. It is a strategic peer in advocacy and public-facing allergy education.
- Allergy UK: Allergy UK is BSACI's primary patient charity partner under the National Allergy Strategy Group, co-developing Allergy Action Plans. Although a patient-facing charity rather than a professional society, it is a key alliance partner and channel for BSACI's public-facing resources.
Regional players
- British Thoracic Society (BTS): BTS is the UK professional society for respiratory medicine, a closely adjacent specialty in which a significant share of BSACI's members also practise. It is a useful peer for benchmarking UK membership, conference, and guideline business models in respiratory.
- Australasian Society of Clinical Immunology and Allergy (ASCIA): ASCIA is the national allergy and clinical immunology society for Australia and New Zealand. It operates a comparable structure (membership, guidelines, conferences, registers) and competes with BSACI for international membership and event attendance.
- Canadian Society of Allergy and Clinical Immunology (CSACI): CSACI is Canada's national specialty society for allergy and clinical immunology, with a similar mandate to produce guidelines and host an annual scientific meeting. It represents a structurally analogous peer in a different geography.
Broad incumbents
- American Academy of Allergy, Asthma & Immunology (AAAAI): AAAAI is the largest established US professional society for allergy/immunology specialists. While geographically distinct, its membership, conference, and guidelines model closely mirrors BSACI's structure and mission, and serves as the North American analogue.
- Royal College of Physicians (RCP): RCP is the broader UK professional body for physicians, with which BSACI has a Major-tier partnership for professional representation. RCP is a peer in the sense of running UK medical education, conferences, and guideline pipelines at greater scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY social profiles
Digital presenceTHE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY financial estimates
Financial estimateRevenue estimate
Valuation estimate
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY leadership team
Management profileNumber of profiles
Profiles9 records
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY
What does THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY do?
BSACI is a UK professional membership society for healthcare practitioners in allergy and clinical immunology, providing tiered individual membership, evidence-based clinical guidelines for secondary and primary care, an annual scientific conference, the Global Allergy Online Symposium, webinars and training workshops, clinical and patient registries, Allergy Action Plans, and patient information resources. It serves over 1,000 members across multiple medical specialties and operates as a registered charity.
Is THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY a public or private company?
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY founded?
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY was founded in 1948. It employs 11 to 50 people.
Where is THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY based?
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY is headquartered in London, United Kingdom, in the Europe region.
How does THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY make money?
Four revenue lines are on record. Membership Fees are the primary driver. The others are corporate Partnerships and Industry Support, meeting Room Hire and annual Conference and Events.
Who are THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY's main competitors?
Direct peers on record are British Society for Immunology (BSI), European Academy of Allergy and Clinical Immunology (EAACI) and World Allergy Organisation (WAO). Others are Anaphylaxis Campaign and Allergy UK. Regional players are British Thoracic Society (BTS), Australasian Society of Clinical Immunology and Allergy (ASCIA) and Canadian Society of Allergy and Clinical Immunology (CSACI). Broad incumbents are American Academy of Allergy, Asthma & Immunology (AAAAI) and Royal College of Physicians (RCP).
Does THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY have an API?
No public API is recorded for THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY.
What industry is THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY in?
THE BRITISH SOCIETY FOR ALLERGY AND CLINICAL IMMUNOLOGY's product category is Professional Medical Society Services. Its primary akta.pro industry code is HLAGAKAI, Clinical Quality Assurance (GCP QA, TMF/QMS oversight), with a secondary code of HLAJAHAL, Workforce Training, Credentialing & Clinical Protocols for Vaccination. Its SIC code is 8600.